reports
- Luis de Toledo Heras
TKA THYSSENKRUPP AG
MT ARCELORMITTAL SA
BEKB BEKAERT SA
AAL ANGLO AMERICAN PLC
APAML APERAM SA
OUT1V OUTOKUMPU OYJ
VCT VICAT-CIMENTS VICAT SA
SSAB A SSAB AB CLASS A
FLY SOCIETE FONCIERE LYONNAISE SA
SZG SALZGITTER AG
VOE VOESTALPINE AG
ELG ELMOS SEMICONDUCTOR SE
ACX ACERINOX SA
NOEJ NORMA GROUP SE
BB SOCIETE BIC SA
NEX NEXANS SA
ERA ERAMET SA
ICAD ICADE SA
NDA AURUBIS AG
GREEN GREENYARD NV
ROYAL VOPAK NV
SFZN SIEGFRIED HOLDING AG
AED AEDIFICA SA
AMG AMG ADVANCED METALLURGICAL GROUP N.V.
ONTEX ONTEX GROUP N.V.
SHOT SCANDIC HOTELS GROUP
ENG ENAGAS SA
RIO RIO TINTO PLC
BHP BHP GROUP LTD
MVC METROVACESA SA
AMAG AMAG AUSTRIA METALL AG
MEDCL MEDINCELL SA
SFQ SAF-HOLLAND SE
- Luis de Toledo Heras
TKA THYSSENKRUPP AG
MT ARCELORMITTAL SA
BEKB BEKAERT SA
AAL ANGLO AMERICAN PLC
APAML APERAM SA
OUT1V OUTOKUMPU OYJ
VCT VICAT-CIMENTS VICAT SA
SSAB A SSAB AB CLASS A
FLY SOCIETE FONCIERE LYONNAISE SA
SZG SALZGITTER AG
VOE VOESTALPINE AG
ELG ELMOS SEMICONDUCTOR SE
ACX ACERINOX SA
NOEJ NORMA GROUP SE
BB SOCIETE BIC SA
NEX NEXANS SA
ERA ERAMET SA
ICAD ICADE SA
NDA AURUBIS AG
GREEN GREENYARD NV
ROYAL VOPAK NV
SFZN SIEGFRIED HOLDING AG
AED AEDIFICA SA
AMG AMG ADVANCED METALLURGICAL GROUP N.V.
ONTEX ONTEX GROUP N.V.
SHOT SCANDIC HOTELS GROUP
ENG ENAGAS SA
RIO RIO TINTO PLC
BHP BHP GROUP LTD
MVC METROVACESA SA
AMAG AMAG AUSTRIA METALL AG
MEDCL MEDINCELL SA
SFQ SAF-HOLLAND SE
- Oliver Metzger
- Stephan Wulf
- Anne-Barbara Nicco
- Damien Choplain
- Martial Descoutures
- Anne-Barbara Nicco
- Damien Choplain
- Martial Descoutures
- Oliver Metzger
- Stephan Wulf
Siegfried once again confirmed in the Dow Jones Sustainability Index E...
Siegfried AG / Key word(s): Sustainability Siegfried once again confirmed in the Dow Jones Sustainability Index Europe 23.12.2024 / 06:30 CET/CEST Media Release Zofingen, December 23, 2024 The DJSI is a highly regarded benchmark for evaluating corporate progress in environmental, social, and governance (ESG) performance across industries. Siegfried stands as the sole Contract Development and Manufacturing Organization represented in the DJSI Europe. Luca Dalla Torre, General Counsel and Chairman of the Siegfried Sustainability Board: "Being recognized as a sustainability leader i...
Changes in Siegfried's senior management team
Siegfried AG / Key word(s): Personnel Changes in Siegfried's senior management team 06.12.2024 / 06:30 CET/CEST Media Release Zofingen, December 6, 2024 Stefan Randl will join as Chief Scientific Officer and member of the Executive Committee as of January 1, 2025. He will succeed Jürgen Roos who has decided to leave the company to take a well-deserved sabbatical. Stefan joins from Evonik, where he has held various leadership positions in several regions over the past 16 years, most recently as Vice President Innovation Management Health Care, based in Frankfurt, Germany, and as Vic...
Siegfried opens new global R&D Center for Drug Substances in Evionnaz
Siegfried AG / Key word(s): Expansion Siegfried opens new global R&D Center for Drug Substances in Evionnaz 19.11.2024 / 07:03 CET/CEST Media Release Zofingen, November 19, 2024 Siegfried (SIX: SFZN), a leading global Contract Development and Manufacturing Organization (CDMO) for the pharmaceutical industry headquartered in Zofingen (Switzerland), inaugurated its new global Research and Development (R&D) Center for Drug Substances at its site in Evionnaz, Switzerland. The 4,500m2 R&D Center houses advanced chemical and analytical facilities, state-of-the-art laboratories, and cutti...
DINAMIQS opens new lab in Zurich
Siegfried AG / Key word(s): Expansion DINAMIQS opens new lab in Zurich 12.11.2024 / 06:30 CET/CEST Media Release Zofingen, November 12, 2024 Siegfried (SIX: SFZN), a leading global Contract Development and Manufacturing Organization (CDMO) for the pharmaceutical industry headquartered in Zofingen (Switzerland), reached another milestone on its path to strengthen its offering in the biologics space, particularly in the fast-growing cell and gene therapy market. DINAMIQS, which became part of the Siegfried group in May 2023, inaugurated its cutting-edge laboratories in Zurich's Bio-T...
Siegfried Holding AG: 1 director
A director at Siegfried Holding AG sold 4,402 shares at 1,130.000CHF and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years...
- Maissa Keskes
- Stephane Houri
- Thomas Zlowodzki
ODDO BHF Small & MIDCAP MORNING NEWS - 10/28/2024
Last Friday, MEPs scrapped the exceptional additional corporate tax proposed by the French government in its PLF 2025. In our view, it would be risky to claim victory prematurely, and this provision could make a comeback during the remainder of the budget debate, in the form initially proposed by the government or in another form. We remain cautious on French equities, as the budget debate remains chaotic and fails to live up to the stakes, as underlined by Moody's downgrade of the so...
CA CARREFOUR SA
MC LVMH MOET HENNESSY LOUIS VUITTON SE
GTT GAZTRANSPORT & TECHNIGAZ SA
UHR SWATCH GROUP LTD. BEARER
RMS HERMES INTERNATIONAL SCA
POM PLASTIC OMNIUM SE
EL ESSILORLUXOTTICA SA
BRBY BURBERRY GROUP PLC
FNAC FNAC DARTY SA
KER KERING SA
TPE PVA TEPLA AG
01913 PRADA S.P.A.
SFZN SIEGFRIED HOLDING AG
MONC MONCLER SPA
BC BRUNELLO CUCINELLI S.P.A.
CFR COMPAGNIE FINANCIERE RICHEMONT SA
WLN WORLDLINE SA
NEXI NEXI S.P.A.
HGEA HGEARS AG
EXENS EXOSENS
- Maissa Keskes
- Stephane Houri
- Thomas Zlowodzki
ODDO BHF Small & MIDCAP MORNING NEWS - 28/10/2024
Les députés ont supprimé vendredi dernier la surtaxe d’Impôt sur les Sociétés proposée par le gouvernement français dans son PLF 2025. Il serait, selon nous, hasardeux de crier victoire trop tôt, et cette disposition pourrait faire son retour durant la suite du débat budgétaire, sous la forme initialement proposée par le gouvernement ou sous une autre. Nous restons prudents sur les actions françaises, le débat budgétaire restant chaotique et pas à la hauteur des enjeux, comme le souli...
CA CARREFOUR SA
MC LVMH MOET HENNESSY LOUIS VUITTON SE
GTT GAZTRANSPORT & TECHNIGAZ SA
UHR SWATCH GROUP LTD. BEARER
RMS HERMES INTERNATIONAL SCA
POM PLASTIC OMNIUM SE
EL ESSILORLUXOTTICA SA
BRBY BURBERRY GROUP PLC
FNAC FNAC DARTY SA
KER KERING SA
TPE PVA TEPLA AG
01913 PRADA S.P.A.
SFZN SIEGFRIED HOLDING AG
MONC MONCLER SPA
BC BRUNELLO CUCINELLI S.P.A.
CFR COMPAGNIE FINANCIERE RICHEMONT SA
WLN WORLDLINE SA
NEXI NEXI S.P.A.
HGEA HGEARS AG
EXENS EXOSENS
- Oliver Metzger
- Stephan Wulf
Siegfried Holding AG : CMD indicated the continuation of Siegfried’s s...
>Marcel Imwinkelried to continue the successful Evolve approach - Siegfried's first CMD took place on 24 October in Barberà del Vallès (Spain), where the company took over production facilities for its Drug Products Division from Novartis in September 2020. The CMD was also a good opportunity to introduce Siegfried's new CEO, Marcel Imwinkelried, who took over his new role on 1 September, to analysts and investors. During the CMD the company did not provide any news s...
Strategy EVOLVE+ paves the way for continued profitable growth
Siegfried AG / Key word(s): Strategic Company Decision Strategy EVOLVE+ paves the way for continued profitable growth 24.10.2024 / 06:30 CET/CEST Media Release Zofingen, October 24, 2024 Siegfried (SIX: SFZN), a leading global Contract Development and Manufacturing Organization (CDMO) for the pharmaceutical industry headquartered in Zofingen (Switzerland), holds its Capital Markets Day today at its site in Barberà del Vallès near Barcelona. At this event, Marcel Imwinkelried, CEO since September 1, 2024, and CFO Reto Suter will provide deeper insight into Siegfried's updated strate...
Siegfried opens new quality control lab in Minden
Siegfried AG / Key word(s): Miscellaneous Siegfried opens new quality control lab in Minden 30.08.2024 / 06:30 CET/CEST Siegfried inaugurated its new state-of-the-art quality control lab in Minden. The new facility further improves the operational efficiency and readies the site for the completion of the new large-scale production plant. Siegfried (SIX: SFZN), a leading global Contract Development and Manufacturing Organization (CDMO) for the pharmaceutical industry headquartered in Zofingen (Switzerland), inaugurated its new state-of-the-art lab in Minden, Germany. The new facilit...
- Oliver Metzger
- Stephan Wulf
Siegfried Holding AG : Strong underlying business offsets multiple tem...
>A strong set of H1 2024 results – 2024 outlook confirmed - At the group level, Siegfried’s H1 2024 sales of CHF 620m (+2.1%), were above our (CHF 614m) and the consensus estimates (CHF 610m). The group’s core EBITDA of CHF 132m (+5.1%) came in 1% stronger than we expected (CHF 131m) and was 2.3% above the consensus (CHF 129m). The relatively strong increase in the company’s EBITDA and the improvement of its core EBITDA margin 21.3% vs 20.7% in H1 2023 must be seen a...
- Oliver Metzger
- Stephan Wulf
Siegfried Holding AG : Broadening of business portfolio should reduce ...
We are initiating coverage of Siegfried with a target price of CHF 1,188 and an Outperform rating. As one of the leading contract development and manufacturing organisations (CDMOs), Siegfried is predestined to benefit from the sustainable drivers of the pharma industry. We expect average sales growth of 9.1% p.a. and EBITDA margin expansion of 280bp to 24.8% out to 2028. Additionally, Siegfried’s solid financials enable it to further improve its competitive position through orga...
Siegfried successfully completes acquisition of an early-phase CDMO in...
Siegfried AG / Key word(s): Acquisition Siegfried successfully completes acquisition of an early-phase CDMO in Wisconsin (US) 02.07.2024 / 06:30 CET/CEST Siegfried (SIX: SFZN) has completed the acquisition of an early-phase CDMO site in Grafton, Wisconsin (US) from Curia Global, strengthening Siegfried's customer offering for Drug Substances in terms of capabilities and geography. The acquisition was announced on June 12, 2024, and was completed on July 1, 2024 with effect as of the same day. Reto Suter, CEO ad interim and CFO of Siegfried: "We warmly welcome our new Siegfried ...
- Dominic Rose
- Naresh Chouhan
Global CDMOs - Overcapacity is Coming (Thematic Research)
We have calculated the significant supply about to enter the biologics manufacturing space & analysed demand growth. Whilst the market assumes an improvement in utilisation from 2024, we forecast there will be significant overcapacity in the coming years resulting in even lower utilisation at an industry level. Our detailed bottom-up analysis shows that total mammalian cell supply is set to grow by 11% p.a. 2023-26 but demand is set to grow just 8% p.a. over the same period. However, much more c...
LONN LONZA GROUP AG
TMO THERMO FISHER SCIENTIFIC INC.
CTLT CATALENT INC
CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC.
A AGILENT TECHNOLOGIES INC.
SRT3 SARTORIUS AG PREF
MRK MERCK KGAA
SFZN SIEGFRIED HOLDING AG
DIM SARTORIUS STEDIM BIOTECH SA
BANB BACHEM HOLDING AG CLASS B
207940 SAMSUNG BIOLOGICS CO. LTD.
EVT EVOTEC AG
AVTR AVANTOR INC.
2269 WUXI BIOLOGICS CAYMAN INC
EAPI EUROAPI
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.